Primary Care Diabetes
Volume 4 , Pages S3-S10 , April 2010

Treat early, treat appropriately

  • Andreas Liebl

      Affiliations

    • Center for Diabetes and Metabolism, Fachklinik, Bad Heilbrunn, Germany
    • Corresponding Author InformationCorresponding author. Andreas Liebl. m&i-Fachklinik Bad Heilbrunn, Wörnerweg 30, 83670 Bad Heilbrunn, Germany. Tel.: +49 80 4618 4106; fax: +49 80 4618 4088
    • ,
  • Guy Rutten

      Affiliations

    • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
    • ,
  • Carlos Abraira

      Affiliations

    • University of Miami Miller School of Medicine, Miami, Florida, USA

References 

  1. M. Danzon, Foreword, R.B. Saltman, A. Rico, W. Boerma, eds, Primary Care in the Driver's Seat? Organizational Reform in European Primary Care, Open University Press, Maidenhead, 2006, xvii–xviii.
  2. Chan M . Primary health care – now more than ever . http://www.who.int/dg/speeches/2008/20081014/en/index.html (accessed July 6, 2009).
  3. Donker GA , Fleming DM , Schellevis FG , Spreeuwenberg P . Differences in treatment regimes, consultation frequency and referral patterns of diabetes mellitus in general practice in five European countries . Fam. Pract. . 2004;21:364–369
  4. Blonde L , Merilainen M , Karwe V , et al.   Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets – the TITRATE study . Diabetes Obes. Metab. . 2009;11:623–631
  5. Davies M , Storms F , Shutler S , et al.   Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine . Diabetes Care . 2005;28:1282–1288
  6. Rubino A , McQuay LJ , Gough SC , et al.   Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with type 2 diabetes: a population-based analysis in the UK . Diabet. Med. . 2007;24:1412–1418
  7. Valensi P , Benroubi M , Borzi V , et al.   The IMPROVE study – a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts . Int. J Clin. Pract. . 2008;62:1809–1819
  8. Nichols GA , Koo YH , Shah SN . Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy . J. Gen. Intern. Med. . 2007;22:453–458
  9. Calvert MJ , McManus RJ , Freemantle N . Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study . Br. J Gen. Pract. . 2007;57:455–460
  10. Khunti K , Gadsby R , Millett C , et al.   Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes . Diabet. Med. . 2007;24:1436–1441
  11. Doran T , Fullwood C , Gravelle H , et al.   Pay-for-performance programs in family practices in the United Kingdom . N. Engl. J Med. . 2006;355:375–384
  12. Hippisley-Cox J , Pringle M . Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: cross sectional survey . Lancet . 2004;364:423–428
  13. Campbell SM , Roland MO , Middleton E , Reeves D . Improvements in quality of clinical care in English general practice 1998–2003: longitudinal observational study . BMJ . 2005;331:1121
  14. Sämann A , Kaiser J , Hunger-Dathe W , et al.   Population-based measurement of quality of diabetes care using HbA1c values in the state of Thuringia/Germany . Exp. Clin. Endocrinol. Diabetes . 2004;112:531–537
  15. Rothe U , Muller G , Schwarz PEH , et al.   Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a Federal State of Germany: a population-based approach to health care research . Diabetes Care . 2008;31:863–868
  16. Rutten GE . [Care of patients with type 2 diabetes mellitus in primary care] . Ned. Tijdschr. Geneeskd. . 2008;152:2389–2394
  17. Wiersma TJ , Heine RJ , Rutten GE . [Summary of the practice guideline ‘Diabetes mellitus type 2’ (first revision) of the Dutch College of General Practitioners] . Ned. Tijdschr. Geneeskd. . 1999;143:1688–1691
  18. van Avendonk MJP , Gorter KJ , van den Donk M , Rutten GEHM . Insulin therapy in type 2 diabetes is no longer a secondary care activity in the Netherlands . Prim. Care Diabetes . 2009;3:23–28
  19. Bouma M , Rutten GE , de Grauw WJ , et al.   [Summary of the practice guideline ‘Diabetes mellitus type 2’ (second revision) from the Dutch College of General Practitioners] . Ned. Tijdschr. Geneeskd. . 2006;150:2251–2256
  20. Sandbaek A , Griffin SJ , Rutten G , et al.   Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study . Diabetologia . 2008;51:1127–1134
  21. Janssen PGH , Gorter KJ , Stolk RP , Rutten GEHM . Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study . Br. J Gen. Pract. . 2009;59:43–48
  22. Alberti KG , Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation . Diabet. Med. . 1998;15:539–553
  23. Lauritzen T , Griffin S , Borch-Johnsen K , et al.   The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening . Int. J Obes. . 2000;24(Suppl. 3):S6–11
  24. Nathan DM , Buse JB , Davidson MB , et al.   Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes . Diabetologia . 2009;52:17–30
  25. van Avendonk MJ , Rutten GE . Insulin therapy in type 2 diabetes: what is the evidence? . Diabetes Obes. Metab. . 2009;11:415–432
  26. German guidelines . http://www.deutsche-diabetesgesellschaft.de/ (accessed April 6, 2009).
  27. Goudswaard AN , Furlong NJ , Valk GD , et al.   Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus . Cochrane Database Syst. Rev. . 2004; CD003418.
  28. Esposito K , Ciotola M , Maiorino MI , et al.   Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial . Ann. Intern. Med. . 2008;149:531–539
  29. Massi Benedetti M , Humburg E , Dressler A , Ziemen M . A one-year, randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with type 2 diabetes . Horm. Metab. Res. . 2003;35:189–196
  30. Rašlová K , Bogoev M , Raz I , et al.   Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes . Diabetes Res. Clin. Pract. . 2004;66:193–201
  31. Haak T , Tiengo A , Draeger E , et al.   Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes . Diabetes Obes. Metab. . 2005;7:56–64
  32. Hermansen K , Davies M , Derezinski T , et al.   A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naïve people with type 2 diabetes . Diabetes Care . 2006;29:1269–1274
  33. Philis-Tsimikas A , Charpentier G , Clauson P , et al.   Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes . Clin. Ther. . 2006;28:1569–1581
  34. Rosenstock J , Davies M , Home PD , et al.   A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes . Diabetologia . 2008;51:408–416
  35. Holman RR , Paul SK , Bethel MA , et al.   10-year follow-up of intensive glucose control in type 2 diabetes . N. Engl. J Med. . 2008;359:1577–1589
  36. The Action to Control Cardiovascular Risk in Diabetes Study Group  . Effects of intensive glucose lowering in type 2 diabetes . N. Engl. J Med. . 2008;358:2545–2559
  37. The ADVANCE Collaborative Group . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes . N. Engl. J Med. . 2008;358:2560–2572
  38. Duckworth W , Abraira C , Moritz T , et al.   Glucose control and vascular complications in veterans with type 2 diabetes . N. Engl. J Med. . 2009;360:129–139
  39. J Calles, M. Banerji, D.E. Bonds, et al., Baseline characteristics and mortality in ACCORD, ADA, New Orleans, LA, USA: 5–9 June (2009) abs 88-OR.
  40. Skyler JS , Bergenstal R , Bonow RO , et al.   Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association . J. Am. Coll. Cardiol. . 2009;53:298–304
  41. Liebl A , Prager R , Binz K , et al.   Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial . Diabetes Obes. Metab. . 2009;11:45–52
  42. Riddle MC , Rosenstock J , Gerich J , on behalf of the Insulin Glargine 4002 Study Investigators  . The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients . Diabetes Care . 2003;26:3080–3086
  43. Hollander P , Cooper J , Bregnhøj J , Pedersen CB . A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes . Clin. Ther. . 2008;30:1976–1987
  44. Dornhorst A , Lüddeke HJ , Sreenan S , et al.   Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE™ study . Int. J Clin. Pract. . 2008;62:659–665

PII: S1751-9918(10)60003-4

doi: 10.1016/S1751-9918(10)60003-4

Primary Care Diabetes
Volume 4 , Pages S3-S10 , April 2010

Article Tools